The Hormone Therapy and Puberty Blocker Child Protection Act introduces stringent regulations concerning medical procedures for minors, specifically prohibiting healthcare providers and public bodies from administering hormones or puberty blockers for gender transition purposes. The Act requires parental notification if a minor engages in gender-affirming actions and mandates parental consent for any gender-affirming care. It also allows parents to pursue civil actions against healthcare providers for violations, with enforcement mechanisms involving the attorney general or district attorneys. The bill amends the Reproductive and Gender-Affirming Health Care Freedom Act to clarify definitions and ensure that minors cannot consent to procedures without parental involvement.

Additionally, the bill expands the definition of individuals who can claim to be aggrieved by violations of the Act, allowing adults, emancipated minors, and minors with parental consent to file actions in district court. It establishes a process for licensing authorities to take action against healthcare providers based on court judgments, including potential license revocation or suspension for gross negligence or willful misconduct. The Act also ensures that prevailing plaintiffs are awarded reasonable attorney fees and costs, with provisions set to take effect on July 1, 2025.

Statutes affected:
introduced version: 24-34-2, 24-34-3, 24-34-4, 24-34-5, 24-35-2, 24-35-3, 24-35-4, 24-35-5, 24-35-6, 24-35-8